Dilantin-125 Suspension
NDC 58151-115
Product Information
Dilantin-125 (phenytoin) is a NDA-approved product labeled by Viatris Specialty Llc. Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). It is supplied as a orange suspension for oral administration. This product entry covers the primary NDC 58151-115 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 58151-115?
What are the uses of this product?
What are Active Ingredients of this product?
- PHENYTOIN 125 mg/5mL - An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PHENYTOIN (UNII: 6158TKW0C5)
- PHENYTOIN (UNII: 6158TKW0C5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- GLYCERIN (UNII: PDC6A3C0OX)
- MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)
- POLYSORBATE 40 (UNII: STI11B5A2X)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SUCROSE (UNII: C151H8M554)
- VANILLIN (UNII: CHI530446X)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1313112 - phenytoin 125 MG in 5 mL Oral Suspension
- RxCUI: 1313112 - phenytoin 25 MG/ML Oral Suspension
- RxCUI: 1313112 - DPH 25 MG/ML Oral Suspension
- RxCUI: 1313112 - phenytoin 100 MG per 4 ML Oral Suspension
- RxCUI: 1313112 - phenytoin 125 MG per 5 ML Oral Suspension
Which are the Pharmacologic Classes of this product?
- Anti-epileptic Agent - [EPC] (Established Pharmacologic Class)
- Cytochrome P450 1A2 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C19 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C8 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2D6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inducers - [MoA] (Mechanism of Action)
- Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
* Please review the full disclaimer at the bottom of this page.